What is Catheter Precision?
Catheter Precision is a medical technology firm dedicated to improving the lives of individuals affected by cardiac arrhythmias. The company specializes in electrophysiology, developing and offering innovative products such as Vivo and LockeT designed to enhance patient care and outcomes. Their strategic focus is on meaningful innovation within the healthcare sector, targeting providers and patients who require advanced cardiac care solutions.
How much funding has Catheter Precision raised?
Catheter Precision has raised a total of $1.6M across 2 funding rounds:
Debt
$150K
Stock/Share Issuance
$1.5M
Debt (2020): $150K with participation from PPP
Stock/Share Issuance (2025): $1.5M, investors not publicly disclosed
Key Investors in Catheter Precision
PPP
Public-Private Partnership
What's next for Catheter Precision?
The substantial enterprise-level funding, highlighted by the recent strategic investment, positions Catheter Precision for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the commercial reach of their innovative electrophysiology products. The company is poised to solidify its position as a leader in cardiac arrhythmia treatment, driving meaningful advancements in patient care.
See full Catheter Precision company page
